SQZ raises $72M series C

Cell therapy company SQZ Biotechnologies Co. (Watertown, Mass.) raised $72 million on Aug. 8 in an oversubscribed, untranched

Read the full 180 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE